We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
Seminari 26/02/2025 at 12:00h | ICIQ Auditorium Prof. Dr. Kilian Muñiz
High-throughput experimentation (HTE) has emerged as a powerful tool in medicinal chemistry to accelerate drug discovery programs by rapidly screening and optimizing reaction conditions. In this poster, we will highlight the work of the SynTech Catalysis Laboratory, which specializes in HTE reaction condition screenings to remove synthetic bottlenecks throughout the medicinal chemistry portfolio within the Global Discovery Chemistry (GDC) organization of Novartis Biomedical Research. Our lab specializes in the optimization of metal-catalyzed reactions commonly encountered in drug discovery programs, including metal-catalyzed cross-coupling reactions, hydrogenations, carbonylations, and asymmetric hydrogenations.
We developed automated workflows and advanced crude analytical techniques to be able to rapidly screen many reaction conditions in parallel, allowing for systematic and efficient optimization of reaction parameters, such as catalysts, ligands, bases, solvents, and additives. This approach not only accelerates access to complex chemical matter for medicinal chemistry programs but also generates clean and reliable data for making informed decisions in the subsequent reaction optimization stages. We introduce some case studies showcasing the successful application of our HTE approach in accelerating drug discovery programs, overcoming synthetic challenges, and improving the efficiency of medicinal chemistry efforts. In conclusion, our catalysis laboratory utilizes HTE chemistry as a powerful tool to accelerate medicinal chemistry programs by systematically screening and optimizing reaction conditions, resulting in more efficient and streamlined drug discovery efforts within Novartis Biomedical Research, Global Discovery Chemistry organization.
Uneix-te al nostre equip per treballar amb investigadors reconeguts i fer front a les novetats
projectes i contribuir a avenços científics significatius